Accessibility options
Translate the page
Queen Mary researchers including Director of Barts Life Sciences Rakesh Uppal help develop nasal spray that prevents Covid-19
Queen Mary University of London professors Rakesh Uppal and Áine McKnight have been at the centre of a new clinical trial finding that pHOXWELL – a nasal spray developed by biotech company pHOXBIO – reduced SARS-CoV-2 infection by 63 per cent in the group given pHOXWELL compared to the group given the placebo. SARS-CoV-2 is the virus that causes Covid-19....
Continue Reading
Barts Life Sciences is recruiting for a data warehouse manager
An exciting opportunity has arisen to work as part of our precision medicine team at Barts Life Sciences. More information and how to apply can be found here: http://jobs.bartshealth.nhs.uk/job/UK/London/London/Barts_Health_NHS_Trust/Administrative_Clerical/Administrative_Clerical-v3441257?_ts=24451 Closing date: 12th September
Continue Reading
AI technology at Barts Life Sciences spares at-risk diabetic patients from limb amputation
Thousands of diabetes patients could be spared a limb amputation thanks to ground-breaking AI technology that has helped Barts Life Sciences identify people at risk from complications. Clinicians at Barts Health NHS Trust, one of the largest trusts in the UK, say it would have taken a clinician over 100 years to review the volume of data analysed in a...
Continue Reading
AI revolution at Barts Health NHS Trust could help thousands of diabetes patients avoid leg and foot amputations
Clinithink artificial intelligence software takes just weeks to sift through data that would take a human more than a century – enabling quicker treatment that could save limbs The Clinithink software analysed 14.2 million medical records and notes to identify patients with diabetic foot disease. A new AI technology being trialled at a major NHS hosptial trust could transform treatment...
Continue Reading
Barts Life Sciences CEO Professor Sir Mark Caulfield to give keynote address at SEHTA MedTech conference October 2021
Barts Life Sciences and SEHTA are delighted to announce that Professor Sir Mark Caulfield, CEO of Barts Life Sciences will be the keynote speaker at the SEHTA 2021 International MedTech Expo & Conference. About the conference: Friday 8th October 2021, Hilton London Tower Bridge Hotel www.sehtamedtechexpo.co.uk The SME focused healthcare event driving collaborations between business, care, clinicians & academics Improving...
Continue Reading